This distinguishes it from GLP-1 agonists like semaglutide, which produce greater weight loss but carry a risk of muscle wasting
District Court for the Eastern District of Pennsylvania
Schumer also talked about her experience on "Watch What Happens Live with Andy Cohen" in 2023, explaining (via Page Six), "I was one of those people that felt so sick and couldn't play with my son
Based on emerging patterns: People who drastically cut calories too quickly Individuals with a history of anxiety or panic symptoms Anyone undergoing rapid dose escalation Users combining retatrutide with stimulants (pre-workout, caffeine, ADHD meds) Individuals losing weight at a very fast rate Retatrutides potency means that too fast, too soon is a real concern
And when they do
Summary of GLP-1 shopping behaviour shifts GLP1 users reduce annual supermarket spend by roughly one third Consumers on GLP1 buy less food overall due to reduced appetite Purchases trend lower in calories sugar carbs and saturated fat Shoppers shift from ultraprocessed foods toward fresher minimally processed options Small individual changes could scale and reshape industry reformulation priorities With offlabel use surging, its virtually impossible to know how many people are currently taking GLP1 drugs like Wegovy or Mounjaro, or how many will be prescribed them in the years ahead
